AU2002345434A1 - Compositions and methods for inhibiting bone resorption - Google Patents

Compositions and methods for inhibiting bone resorption

Info

Publication number
AU2002345434A1
AU2002345434A1 AU2002345434A AU2002345434A AU2002345434A1 AU 2002345434 A1 AU2002345434 A1 AU 2002345434A1 AU 2002345434 A AU2002345434 A AU 2002345434A AU 2002345434 A AU2002345434 A AU 2002345434A AU 2002345434 A1 AU2002345434 A1 AU 2002345434A1
Authority
AU
Australia
Prior art keywords
compositions
methods
bone resorption
inhibiting bone
inhibiting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002345434A
Inventor
John E. Fisher
Alfred A. Reszka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of AU2002345434A1 publication Critical patent/AU2002345434A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
AU2002345434A 2001-06-05 2002-05-31 Compositions and methods for inhibiting bone resorption Abandoned AU2002345434A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US29587701P 2001-06-05 2001-06-05
US60/295,877 2001-06-05
PCT/US2002/017141 WO2002098353A2 (en) 2001-06-05 2002-05-31 Compositions and methods for inhibiting bone resorption

Publications (1)

Publication Number Publication Date
AU2002345434A1 true AU2002345434A1 (en) 2002-12-16

Family

ID=23139585

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002345434A Abandoned AU2002345434A1 (en) 2001-06-05 2002-05-31 Compositions and methods for inhibiting bone resorption

Country Status (2)

Country Link
AU (1) AU2002345434A1 (en)
WO (1) WO2002098353A2 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2016467A1 (en) * 1989-06-05 1990-12-05 Martin Eisman Method for treating peripheral atherosclerotic disease employing an hmg coa reductase inhibitor and/or a squalene synthetase inhibitor

Also Published As

Publication number Publication date
WO2002098353A3 (en) 2003-02-27
WO2002098353A2 (en) 2002-12-12

Similar Documents

Publication Publication Date Title
AU2002328762A1 (en) Osteophilic implants
EP1446114A4 (en) Compositions and methods for treating osteoporosis
AU2002357119A1 (en) Mitocidal compositions and methods
AU2002244116A1 (en) Bone implants and methods
AU2003276014A1 (en) Bone growth compositions and methods
AU2002340306A1 (en) Bone implant and insertion tools
GB0201866D0 (en) Method and compositions for disinfecting hard surfaces
EP1088333A4 (en) Compositions and methods for inhibiting bone resorption
AU2002258592A1 (en) Compositions and methods for modulating bone mineral deposition
AU2002366381A1 (en) Spinal implants
AU2002331890A1 (en) Compositions and methods involved in bone growth
AU2002359715A1 (en) Implant coatings
AU2002357748A1 (en) Osteopontin-related compositions and methods
AU2002326745A1 (en) Compositions and methods for generating antigen-binding units
AU2002321019A1 (en) Bone implant
AU2002351200A1 (en) Compositions and methods for inhibiting prenyltransferases
AU2002303552A1 (en) Methods and compositions for prevention of angioproliferation
AU2001283226A1 (en) Methods and compositions for inhibiting rad51
EP1089750A4 (en) Compositions and methods for inhibiting bone resorption
AU2002322333A1 (en) Compositions and methods for labeling oligonucleotides
AU2002365136A1 (en) Compositions and methods for controlled release
EP1397146A4 (en) Compositions and methods for inhibiting bone resorption
AU2002345434A1 (en) Compositions and methods for inhibiting bone resorption
AU2002359869A1 (en) Pak5-related compositions and methods
AU2002342188A1 (en) Methods and compositions for treating flavivirus-mediated disease

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase